2% of the population suffers from chronic wounds.
Wound treatment start-up Polyheal Ltd. has obtained EU CE Mark certification for its treatment for chronic wounds. The company says that it product can shorten the healing process, reduce patient suffering, and save costs.
Polyheal CEO Jordan Rubinson said that the product has been shown to be effective, and that the company would launch the product in Europe in a few months.
Polyheal is a portfolio company of IDB Holding Corp. Ltd. (TASE:IDBH) unit Clal Biotechnology Industries Ltd. (TASE: CBI). CBI's share fell 6.5% today to NIS 3.15, giving a market cap of NIS 299 million.
2% of the population suffers from chronic wounds.
Published by Globes [online], Israel business news - www.globes-online.com - on October 28, 2008
© Copyright of Globes Publisher Itonut (1983) Ltd. 2008